What’s New?
What’s New?
Adelphi Attends Trio Of Exciting Conferences
Over the last few months our team has been busy attending a range of interesting conferences to discuss all things innovation and healthcare research. We’ve attended conferences by some of the most interesting voices in the industry, including Intellus, JP Morgan...
Highlights from A&I Summit 2023
Our team here at Adelphi are always busy keeping on top of the latest trends and developments in pharma and healthcare research, and this month has been no different, with Adelphi attending the A&I Summit in Barcelona. The Analytics & Insights Summit was held...
Adelphi Research is celebrating 33 years in business
Every day, we are inspired to make a difference to patient lives all across the world. From day one, it’s always been important to us to keep evolving and transforming to put forth exceptional results to continue improving the lives of patients. With that, we’ve...
Barriers and Biases in Pharma Research – Part Three. A collaboration with Nick Southgate
In the third article in our series, we start by considering respondents cannot tell us everything. To get to insightful ideas that change behaviour and help clients’ businesses we need to take some more steps. First, we need to ask better questions. We’ll start by...
Barriers and Biases in Pharma Research – Part Two. A collaboration with Nick Southgate
In the first article in our Barriers and Biases in Pharma Research series, we looked at the role of cognitive biases and heuristics in simplifying complex choices to produce imperfect but ‘good enough’ decision–making. We might think there are times when ‘good enough’...
Barriers and Biases in Pharma Research – Part One. A collaboration with Nick Southgate
Why is this approach to economic analysis, which applies psychological insights from individual behaviour, sustaining its relevance?
Barriers and Biases in Pharma Research – Part One. A collaboration with Nick Southgate
Why is this approach to economic analysis, which applies psychological insights from individual behaviour, sustaining its relevance?
Biomarkers in Rheumatology: The Present and Future Outlook
Rheumatoid disorders ranging from Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) to ankylosing spondylitis (AS) have seen huge therapeutic advancements over the last decade.
Highlights from Reuters Pharma Europe 2021
Did you attend Reuters Pharma Europe 2021 which took place virtually on 11 – 22 October? Our team did and they captured some interesting takeaways on the hottest themes and key case studies.
Privacy Policy | Privacy Shield | California Consumer Privacy | Recruitment Privacy Notice
Copyright © 2020 - 2022 Adelphi Research | Designed by Embrace Marketing Ltd
Company Reg No: 1975338 Registered Office : Bankside3 90-100 Southwark St, London SE1 0SW